Michael U. Callaghan

5.1k citations
89 papers · 3.9k · 2 hit papers · h-index 26

Impact in

  • Hematology top 0.5%
    • Hemophilia Treatment and Research
    • Platelet Disorders and Treatments
    • Endoplasmic Reticulum Stress and Disease

Papers in

    • Hemophilia Treatment and Research 39
    • Platelet Disorders and Treatments 10
    • Hemoglobinopathies and Related Disorders 18

Michael U. Callaghan

86 papers receiving 3.9k citations

Michael U. Callaghan's Hit Papers

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors 2018 · 604 citations
6040+3+6Years since publication250500750

Peers

Michael U. Callaghan
Comparison fields: 5 of 100
  • Hematology 2.5k
  • Cell Biology 396
  • Genetics 215
  • Drug Discovery 2
  • Complementary and alternative medicine 45
Replace Masood A. Shammas with:
Masood A. Shammas United States
Patricia B. Maguire Ireland
Richard F. Branda United States
Roberto Passetto Falcão Brazil
White Jg United States
Jan‐Henning Klusmann Germany
Erica Sparkenbaugh United States
Erica De Candia Italy
Yelena Z. Ginzburg United States
François Girodon France
Michael U. Callaghan relative to Masood A. Shammas United States Masood A. Shammas's profile →
Citations per field
00.5×2×4×6×7.6×
Masood A. Shammas · 1×
Citations per year

Countries citing papers authored by Michael U. Callaghan

Since Specialization
Citations

This map shows the geographic impact of Michael U. Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael U. Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael U. Callaghan more than expected).

Fields of papers citing papers by Michael U. Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael U. Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael U. Callaghan. The network helps show where Michael U. Callaghan may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael U. Callaghan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael U. Callaghan Line = papers co-authored together Michael U. Callaghan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Hit paper breakdown →
2017892
2
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
Hit paper breakdown →
2018604
3 2008506
4 2015249
5 2020221
6 202288
7 201876
8 202076
9 200862
10 202159
11 201453
12 202048
13 201747
14 201845
15 202144
16 201940
17 201139
18 201938
19 201837
20 202035

About Michael U. Callaghan

Michael U. Callaghan is a scholar working on Hematology, Genetics, Cell Biology, Pediatrics, Perinatology and Child Health and Immunology, having authored 89 papers that have together received 3.9k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (39 papers), Hemoglobinopathies and Related Disorders (18 papers), Endoplasmic Reticulum Stress and Disease (14 papers), Platelet Disorders and Treatments (10 papers), Neonatal Health and Biochemistry (2 papers), Erythrocyte Function and Pathophysiology (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Heavy Metal Exposure and Toxicity (1 paper). The work is most often cited by research in Hematology (2.5k citations), Cell Biology (396 citations), Genetics (215 citations), Drug Discovery (2 citations) and Complementary and alternative medicine (45 citations). Michael U. Callaghan has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Johnny Ndoni Mahlangu, Gallia G. Levy, Rebecca Kruse‐Jarres, Claude Négrier, Midori Shima, Johannes Oldenburg, Elina Asikanius, Christophe Schmitt, Guy A. Young and Elena Santagostino. Their work appears in journals such as Blood, Haemophilia, Pediatric Blood & Cancer, Journal of Clinical Medicine and Journal of Pediatric Hematology/Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact